Defunct Company
Total Trials
5
As Lead Sponsor
0
As Collaborator
Total Enrollment
1,304
NCT02308527
Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children
Phase: Phase 2
Role: Collaborator
Start: Jul 31, 2013
Completion: Feb 28, 2026
NCT02817997
International Registry for Patients With Castleman Disease
Phase: N/A
Start: Oct 31, 2016
Completion: Sep 30, 2027
NCT04191421
Siltuximab and Spartalizumab in Patients With Metastatic Pancreatic Cancer
Phase: Phase 1/2
Start: Jan 17, 2020
Completion: Apr 5, 2023
NCT05316116
Siltuximab in Large Granular Lymphocytic Leukemia (LGLL)
Phase: Early Phase 1
Start: Feb 15, 2023
Completion: Oct 18, 2024
NCT06485947
Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma
Phase: Phase 1
Start: Jan 28, 2025
Completion: Dec 1, 2031